Cleared Traditional

K201577 - MatriDerm (FDA 510(k) Clearance)

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2021
Decision
210d
Days
-
Risk

K201577 is an FDA 510(k) clearance for the MatriDerm. Classified as Wound Dressing With Animal-derived Material(s) (product code KGN).

Submitted by Medskin Solutions Dr. Suwelack AG (Billerbeck, DE). The FDA issued a Cleared decision on January 7, 2021 after a review of 210 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Medskin Solutions Dr. Suwelack AG devices

Submission Details

510(k) Number K201577 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 11, 2020
Decision Date January 07, 2021
Days to Decision 210 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
96d slower than avg
Panel avg: 114d · This submission: 210d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KGN Wound Dressing With Animal-derived Material(s)
Device Class -

Regulatory Peers - KGN Wound Dressing With Animal-derived Material(s)

All 182
Devices cleared under the same product code (KGN) and FDA review panel - the closest regulatory comparables to K201577.
Derma-Gide
K260532 · Geistlich Pharma AG · Mar 2026
LacertaMatrix
K260218 · Lacerta Life Sciences · Feb 2026
CollOvine™ Wound Powder
K253140 · Ovigenex, LLC · Feb 2026
Device 104 Particulate
K251323 · Geistlich Pharma AG · Jan 2026
LacertaMatrix
K252673 · Lacerta Life Science · Dec 2025
Theracor
K253339 · Stimlabs, LLC · Dec 2025